tobramycin has been researched along with rifampin in 64 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 15 (23.44) | 18.7374 |
1990's | 5 (7.81) | 18.2507 |
2000's | 21 (32.81) | 29.6817 |
2010's | 20 (31.25) | 24.3611 |
2020's | 3 (4.69) | 2.80 |
Authors | Studies |
---|---|
Kiraz, M; Küçükgüzel, I; Küçükgüzel, SG; Rollas, S | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Duewelhenke, N; Eysel, P; Krut, O | 1 |
Cheung, A; Götz, F; Herbert, S; Meehl, M | 1 |
Beceiro, A; Bou, G; Canle, D; Fernández, A; Lasa, I; Latasa, C; Mallo, S; Molina, F; Pérez, A; Pérez, S; Poza, M; Tomás, Mdel M; Villanueva, R | 1 |
Amblard, M; Bastide, L; Gualtieri, M; Leonetti, JP; Martinez, J; Pugniere, M; Roquet, F; Villain-Guillot, P | 1 |
Chen, T; Khalil, H; Riffon, R; Wang, R; Wang, Z | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Alba, V; Blasco, MD; Espinal, P; Fernández-Cuenca, F; Marti, S; Pascual, A; Ruiz, M; Sánchez-Céspedes, J; Vila, J | 1 |
Cattoir, V; Nordmann, P; Poirel, L | 1 |
del Pozo, JL; Mandrekar, JN; Patel, R; Rouse, MS; Sampedro, MF; Steckelberg, JM | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Akierman, S; Ceri, H; Harrison, JJ; Stremick, CA; Turner, RJ; Vacchi-Suzzi, C; Wade, WD | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Gaillard, JL; Jackson, M; McDonnell, G; Niederweis, M; Skovierová, H; Svetlíková, Z | 1 |
Courvalin, P; Coyne, S; Guigon, G; Périchon, B | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Glen, RC; Lowe, R; Mitchell, JB | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Brozovic, A; Dowson, CG; Gazvoda, M; Košmrlj, J; Lloyd, A; Osmak, M; Proud, C; Roper, DI; Vajs, J | 1 |
Ashenden, S; Bender, A; Cokol, M; Karakoc, I; Kuru, N; Mason, DJ; Meral, S; Stott, I; Weinstein, ZB | 1 |
Domalaon, R; Gorityala, BK; Goswami, S; Idowu, T; Lyu, Y; Schweizer, F; Shan, A; Yang, X; Zhanel, GG | 1 |
Arthur, G; Idowu, T; Schweizer, F; Zhanel, GG | 1 |
Bera, S; Mondal, D | 1 |
Ammeter, D; Idowu, T; Rossong, H; Schweizer, F; Zhanel, GG | 1 |
Weinstein, AJ | 1 |
Farrar, WE; Saad, AF | 1 |
Fieker, DH; McHenry, MC | 1 |
Goncharova, EI | 1 |
Chan, MK; Cheng, IK; Ng, WS | 1 |
Akimoto, Y; Fujii, A; Kaneko, K | 1 |
Watanakunakorn, C | 1 |
Durgham, SM; Ishag, AJ; Shibl, AM | 1 |
Chantrenne, ML; De Knop, RJ; Van Caekenberghe, DL; Wouters, RM | 1 |
Borges, LF; Chapman, PH | 1 |
Bryant, RE; Chamovitz, B; Gilbert, DN; Hartstein, AI | 1 |
Kanai, S; Natsume, H; Yamamoto, M | 1 |
Yee, RB; Yu, VL; Zuravleff, JJ | 1 |
Chervenick, P; Diven, WF; Muder, RR; Yu, VL; Zuravleff, JJ | 1 |
DeHertogh, D; Peacock, JE; Tashjian, L; Yu, VL; Zuravleff, JJ | 1 |
Arnulf, JJ; Diesnis, P; Dor, V; Gioanni, T; Jourdan, J; Kreitmann, P; Mermet, B; Schmitt, R | 1 |
Erlendsdóttir, H; Gottfredsson, M; Gudmundsson, A; Gudmundsson, S | 1 |
Craig, WA; Gudmundsson, S; Vogelman, B | 1 |
Gilbert, C; Hussein, A; Meisenberg, B; Perfect, J; Peters, WP; Ross, M; Vredenburgh, J | 1 |
Bingen, E; Bonacorsi, S; Fitoussi, F; Lhopital, S | 1 |
Contag, PR; Francis, KP; Kadurugamuwa, JL; Kimura, R; Purchio, T; Sin, LV; Yu, J | 1 |
Li, RC; Tang, MC | 1 |
Ariza, J; Ayats, J; Borraz, C; Cabellos, C; Corbella, X; Doménech, A; Gudiol, F; Montero, A; Tubau, F | 1 |
Bruneval, P; Coggia, M; Goëau-Brissonnière, O; Javerliat, I | 1 |
Coggia, M; Gaillard, JL; Goëau-Brissonnière, O; Javerliat, I; Sivadon-Tardy, V | 1 |
Brown, SM; Fanning, WL; Raflo, GT | 1 |
Juthani, V; Lisman, RD; Rizk, SS; Zoumalan, CI | 1 |
Pacheco, SM; Patel, JA; Postelnick, M; Sutton, S | 1 |
Bahador, A; Hashemizadeh, Z; Mansoori, N; Pourakbari, B; Raoofian, R; Rostami, H; Taheri, M | 1 |
Blanchemain, N; Chai, F; Goube, M; Hildebrand, HF; Martel, B; Maton, M; Neut, C; Taha, M | 1 |
Mataraci-Kara, E; Ozbek Celik, B; Yilmaz, M | 1 |
Dahners, L; Del Gaizo, DJ; Ledbetter, E; Liu, A; Medda, S; van der Horst, AS; Weinhold, P | 1 |
Domalaon, R; Lyu, Y; Schweizer, F; Yang, X; Zhanel, GG | 1 |
Likine, EF; Seligson, D | 1 |
Bragantini, D; Carrara, E; Cattaneo, P; Chiamenti, M; Ellis, S; Franceschi, F; Giske, CG; Lodise, T; Menchinelli, G; Piddock, LJV; Righi, E; Sanguinetti, M; Savoldi, A; Scudeller, L; Tacconelli, E | 1 |
Collier, CD; Greenfield, EM; Higashihira, S; Kittaka, M; Natoli, RM; Simpson, SJ | 1 |
Bhamare, P; Dunman, PM; Johnson, W; Kinn, B; Laskey, E; Mei, JA; Nolin, L; Stalker, C; Wozniak, RAF | 1 |
5 review(s) available for tobramycin and rifampin
Article | Year |
---|---|
Insights of synthetic analogues of anti-leprosy agents.
Topics: Humans; Leprostatic Agents; Leprosy; Structure-Activity Relationship | 2019 |
Newer antibacterial and antimycotic drugs. Critical appraisal.
Topics: Amikacin; Anti-Bacterial Agents; Antifungal Agents; Cephalosporins; Clindamycin; Flucytosine; Humans; Imidazoles; Penicillins; Rifampin; Spectinomycin; Sulfamethoxazole; Tetracyclines; Tobramycin; Trimethoprim | 1978 |
[New developments in the treatment of typhoid (review of non-Soviet literature)].
Topics: Amoxicillin; Ampicillin; Anti-Infective Agents; Carrier State; Cefamandole; Cefazolin; Chloramphenicol; Doxycycline; Humans; Rifampin; Sulfamethoxazole; Tobramycin; Trimethoprim; Typhoid Fever | 1979 |
Shunt infections: prevention and treatment.
Topics: Amikacin; Anti-Bacterial Agents; Bacterial Infections; Cerebrospinal Fluid Shunts; Drug Resistance, Microbial; Drug Therapy, Combination; Escherichia coli Infections; Gentamicins; Humans; Injections, Intravenous; Injections, Intraventricular; Klebsiella Infections; Leukocytes; Meningitis; Premedication; Pseudomonas Infections; Reoperation; Rifampin; Staphylococcal Infections; Staphylococcus epidermidis; Tobramycin; Vancomycin | 1985 |
Systematic review and meta-analysis of in vitro efficacy of antibiotic combination therapy against carbapenem-resistant Gram-negative bacilli.
Topics: Amikacin; Anti-Bacterial Agents; Azabicyclo Compounds; Carbapenems; Ceftazidime; Cephalosporins; Colistin; Drug Combinations; Drug Resistance, Bacterial; Drug Synergism; Drug Therapy, Combination; Fosfomycin; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; In Vitro Techniques; Microbial Sensitivity Tests; Polymyxins; Rifampin; Tazobactam; Tobramycin | 2021 |
2 trial(s) available for tobramycin and rifampin
Article | Year |
---|---|
A randomized prospective trial of three different regimens of treatment of peritonitis in patients on continuous ambulatory peritoneal dialysis.
Topics: Administration, Oral; Adult; Anti-Bacterial Agents; Bacteria; Cephalothin; Drug Therapy, Combination; Female; Humans; Injections, Intraperitoneal; Male; Middle Aged; Ofloxacin; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Prospective Studies; Randomized Controlled Trials as Topic; Rifampin; Tobramycin | 1990 |
Sequential prophylactic oral and empiric once-daily parenteral antibiotics for neutropenia and fever after high-dose chemotherapy and autologous bone marrow support.
Topics: Administration, Oral; Adult; Antineoplastic Combined Chemotherapy Protocols; Bacterial Infections; Bone Marrow Purging; Bone Marrow Transplantation; Breast Neoplasms; Ciprofloxacin; Drug Administration Schedule; Drug Therapy, Combination; Female; Fever; Humans; Injections, Intravenous; Middle Aged; Neutropenia; Rifampin; Stem Cell Transplantation; Tobramycin; Vancomycin | 1994 |
57 other study(ies) available for tobramycin and rifampin
Article | Year |
---|---|
Some 3-thioxo/alkylthio-1,2,4-triazoles with a substituted thiourea moiety as possible antimycobacterials.
Topics: Animals; Antitubercular Agents; Chlorocebus aethiops; Microbial Sensitivity Tests; Mycobacterium fortuitum; Mycobacterium tuberculosis; Thiourea; Triazoles; Vero Cells | 2001 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Influence on mitochondria and cytotoxicity of different antibiotics administered in high concentrations on primary human osteoblasts and cell lines.
Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; Antimycin A; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cells, Cultured; Chloramphenicol; Clindamycin; Dose-Response Relationship, Drug; Fluoroquinolones; Glycolysis; HeLa Cells; Humans; Lactic Acid; Linezolid; Macrolides; Mitochondria; Osteoblasts; Oxazolidinones; Rotenone; Tetracyclines; Time Factors | 2007 |
Interaction of the GraRS two-component system with the VraFG ABC transporter to support vancomycin-intermediate resistance in Staphylococcus aureus.
Topics: Anti-Bacterial Agents; ATP-Binding Cassette Transporters; Bacterial Proteins; Gene Expression Regulation, Bacterial; Humans; Microbial Sensitivity Tests; Polymyxin B; Signal Transduction; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2007 |
Cloning, nucleotide sequencing, and analysis of the AcrAB-TolC efflux pump of Enterobacter cloacae and determination of its involvement in antibiotic resistance in a clinical isolate.
Topics: Bacterial Proteins; Base Sequence; beta-Lactamases; Carrier Proteins; Cloning, Molecular; DNA, Bacterial; Drug Resistance, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Genes, MDR; Genetic Vectors; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Porins | 2007 |
Structure-activity relationships of phenyl-furanyl-rhodanines as inhibitors of RNA polymerase with antibacterial activity on biofilms.
Topics: Animals; Anti-Bacterial Agents; Biofilms; CHO Cells; Cricetinae; Cricetulus; DNA-Directed RNA Polymerases; Furans; Gram-Positive Bacteria; Microbial Sensitivity Tests; Rhodanine; Staphylococcus epidermidis; Structure-Activity Relationship | 2007 |
Synergy between polyethylenimine and different families of antibiotics against a resistant clinical isolate of Pseudomonas aeruginosa.
Topics: Aminoglycosides; Anti-Bacterial Agents; Carbenicillin; Ceftazidime; Ciprofloxacin; Drug Resistance, Bacterial; Drug Synergism; Humans; Microbial Sensitivity Tests; Novobiocin; Ofloxacin; Piperacillin; Polyethyleneimine; Pseudomonas aeruginosa; Pseudomonas Infections; Rifampin; Ticarcillin; Tobramycin | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Characterization of the carbapenem-hydrolyzing oxacillinase oxa-58 in an Acinetobacter genospecies 3 clinical isolate.
Topics: Acinetobacter; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; beta-Lactamases; Carbapenems; Humans; Imipenem; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Sequence Analysis, DNA | 2008 |
Plasmid-mediated quinolone resistance pump QepA2 in an Escherichia coli isolate from France.
Topics: Aged; Base Sequence; DNA Primers; DNA, Bacterial; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Fluoroquinolones; France; Genes, Bacterial; Humans; Models, Genetic; Molecular Sequence Data; Plasmids | 2008 |
Effect of electrical current on the activities of antimicrobial agents against Pseudomonas aeruginosa, Staphylococcus aureus, and Staphylococcus epidermidis biofilms.
Topics: Anti-Infective Agents; Biofilms; Bioreactors; Electricity; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Staphylococcus aureus; Staphylococcus epidermidis | 2009 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
The chromosomal toxin gene yafQ is a determinant of multidrug tolerance for Escherichia coli growing in a biofilm.
Topics: Bacterial Toxins; Biofilms; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Proteins; Plankton | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Role of porins in the susceptibility of Mycobacterium smegmatis and Mycobacterium chelonae to aldehyde-based disinfectants and drugs.
Topics: Antitubercular Agents; Disinfectants; Drug Resistance, Bacterial; Glutaral; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Mycobacterium chelonae; Mycobacterium smegmatis; o-Phthalaldehyde; Porins | 2009 |
Screening and quantification of the expression of antibiotic resistance genes in Acinetobacter baumannii with a microarray.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; DNA, Bacterial; DNA, Complementary; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Genes, MDR; Metals, Heavy; Microbial Sensitivity Tests; Mutation; Oligonucleotide Array Sequence Analysis; Reproducibility of Results; Reverse Transcriptase Polymerase Chain Reaction; RNA, Bacterial | 2010 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Diaryltriazenes as antibacterial agents against methicillin resistant Staphylococcus aureus (MRSA) and Mycobacterium smegmatis.
Topics: Anti-Bacterial Agents; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mycobacterium smegmatis; Triazenes | 2017 |
Prediction of Antibiotic Interactions Using Descriptors Derived from Molecular Structure.
Topics: Anti-Bacterial Agents; Drug Interactions; Molecular Structure | 2017 |
Amphiphilic Tobramycin-Lysine Conjugates Sensitize Multidrug Resistant Gram-Negative Bacteria to Rifampicin and Minocycline.
Topics: Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; Hemolysis; Lysine; Microbial Sensitivity Tests; Minocycline; Models, Biological; Rifampin; Tobramycin | 2017 |
Heterodimeric Rifampicin-Tobramycin conjugates break intrinsic resistance of Pseudomonas aeruginosa to doxycycline and chloramphenicol in vitro and in a Galleria mellonella in vivo model.
Topics: Animals; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Chloramphenicol; Doxycycline; Drug Resistance, Multiple, Bacterial; Drug Synergism; HEK293 Cells; Hep G2 Cells; Humans; Membrane Transport Proteins; Microbial Sensitivity Tests; Molecular Structure; Moths; Pseudomonas aeruginosa; Rifampin; Swine; Tobramycin | 2019 |
Homodimeric Tobramycin Adjuvant Repurposes Novobiocin as an Effective Antibacterial Agent against Gram-Negative Bacteria.
Topics: Anti-Bacterial Agents; Dimerization; Gram-Negative Bacteria; Novobiocin; Tobramycin | 2019 |
Newer antibiotics: guidelines for use.
Topics: Amoxicillin; Anti-Bacterial Agents; Carbenicillin; Cephalosporins; Clindamycin; Doxycycline; Drug Combinations; Gentamicins; Humans; Minocycline; Rifampin; Spectinomycin; Sulfamethoxazole; Tobramycin; Trimethoprim | 1976 |
Antimicrobial resistance and R factors in Salmonella isolated from humans and animals in Georgia and South Carolina.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Gentamicins; Georgia; Humans; Kanamycin; Microbial Sensitivity Tests; Nitrofurantoin; Penicillin Resistance; R Factors; Rifampin; Salmonella; Serotyping; South Carolina; Spectinomycin; Streptomycin; Sulfamethoxazole; Tetracycline; Tobramycin; Trimethoprim | 1977 |
[Susceptibility and beta-lactamase-producing strains of methicillin-resistant Staphylococcus aureus].
Topics: Ampicillin Resistance; beta-Lactamases; Cefazolin; Erythromycin; Methicillin Resistance; Minocycline; Rifampin; Staphylococcus aureus; Tobramycin | 1989 |
In-vitro activity of teicoplanin alone and in combination with rifampicin, gentamicin or tobramycin against coagulase-negative staphylococci.
Topics: Coagulase; Drug Synergism; Gentamicins; Glycopeptides; Microbial Sensitivity Tests; Rifampin; Staphylococcus; Teicoplanin; Tobramycin | 1987 |
In vitro susceptibility of methicillin-resistant Staphylococcus aureus to imipenem and other antimicrobial agents.
Topics: Amikacin; Anti-Bacterial Agents; Cefepime; Cephalosporins; Clindamycin; Fusidic Acid; Imipenem; Methicillin; Microbial Sensitivity Tests; Norfloxacin; Pefloxacin; Penicillin Resistance; Rifampin; Staphylococcus aureus; Thienamycins; Tobramycin; Vancomycin | 1987 |
Comparison of serum bactericidal activities of three experimental antibiotic regimens against Corynebacterium group JK.
Topics: Anti-Bacterial Agents; Cefazolin; Corynebacterium; Drug Synergism; Drug Therapy, Combination; Microbial Sensitivity Tests; Rifampin; Species Specificity; Tobramycin | 1987 |
Prosthetic valve endocarditis caused by Staphylococcus epidermidis. Development of rifampin resistance during vancomycin and rifampin therapy.
Topics: Drug Resistance, Microbial; Drug Therapy, Combination; Endocarditis, Bacterial; Female; Heart Valve Prosthesis; Humans; Male; Middle Aged; Reoperation; Retrospective Studies; Rifampin; Staphylococcal Infections; Staphylococcus epidermidis; Tobramycin; Vancomycin | 1985 |
[The effectiveness of a combination of trimethoprim plus rifampicin and local injection of antibiotics into the prostate in chronic bacterial prostatitis].
Topics: Adult; Bacterial Infections; Chronic Disease; Drug Combinations; Drug Evaluation; Drug Therapy, Combination; Humans; Injections; Male; Middle Aged; Prostate; Prostatitis; Rifampin; Tobramycin; Trimethoprim | 1985 |
Ticarcillin-tobramycin-rifampin: in vitro synergy of the triplet combination against Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Drug Combinations; Drug Synergism; Microbial Sensitivity Tests; Penicillins; Pseudomonas aeruginosa; Rifampin; Ticarcillin; Tobramycin | 1983 |
Addition of rifampin to ticarcillin-tobramycin combination for the treatment of Pseudomonas aeruginosa infections: assessment in a neutropenic mouse model.
Topics: Animals; Cyclophosphamide; Drug Evaluation, Preclinical; Drug Therapy, Combination; Endotoxins; Exotoxins; Female; Mice; Microbial Sensitivity Tests; Neutropenia; Penicillin Resistance; Penicillins; Pseudomonas aeruginosa; Pseudomonas Infections; Rifampin; Ticarcillin; Tobramycin | 1984 |
Addition of rifampin to carboxypenicillin-aminoglycoside combination for the treatment of Pseudomonas aeruginosa infection: clinical experience with four patients.
Topics: Adult; Anti-Bacterial Agents; Carbenicillin; Drug Therapy, Combination; Gentamicins; Humans; Male; Pseudomonas Infections; Rifampin; Ticarcillin; Tobramycin | 1984 |
[Pseudomonas endocarditis on aortic valve prosthesis. Successful treatment by association of tobramycin-rifampicin-colistin and two reinterventions. Follow-up of 5 years (author's transl)].
Topics: Adult; Aortic Valve; Colistin; Drug Therapy, Combination; Endocarditis, Bacterial; Heart Valve Prosthesis; Humans; Male; Postoperative Complications; Pseudomonas Infections; Rifampin; Tobramycin | 1981 |
Different patterns of bacterial DNA synthesis during postantibiotic effect.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Dicloxacillin; DNA, Bacterial; Escherichia coli; Gentamicins; Imipenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Rifampin; Staphylococcus aureus; Tobramycin; Vancomycin | 1995 |
Decreased bactericidal activity during the period of the postantibiotic effect.
Topics: Ampicillin; Bacteria; Bacterial Physiological Phenomena; Cefamandole; Drug Therapy, Combination; Erythromycin; Escherichia coli; Gentamicins; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Nafcillin; Regression Analysis; Rifampin; Staphylococcus aureus; Time Factors; Tobramycin | 1994 |
Comparative in vitro activities of meropenem, imipenem, temocillin, piperacillin, and ceftazidime in combination with tobramycin, rifampin, or ciprofloxacin against Burkholderia cepacia isolates from patients with cystic fibrosis.
Topics: Burkholderia cepacia; Burkholderia Infections; Ceftazidime; Ciprofloxacin; Cystic Fibrosis; Drug Synergism; Drug Therapy, Combination; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Penicillins; Piperacillin; Rifampin; Thienamycins; Tobramycin | 1999 |
Rapid direct method for monitoring antibiotics in a mouse model of bacterial biofilm infection.
Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; Biofilms; Catheterization; Ciprofloxacin; Colony Count, Microbial; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Monitoring; Luminescent Measurements; Mice; Rifampin; Staphylococcus aureus; Tobramycin | 2003 |
Post-antibiotic effect induced by an antibiotic combination: influence of mode, sequence and interval of exposure.
Topics: Drug Therapy, Combination; Escherichia coli; Microbial Sensitivity Tests; Rifampin; Time Factors; Tobramycin | 2004 |
Antibiotic combinations for serious infections caused by carbapenem-resistant Acinetobacter baumannii in a mouse pneumonia model.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Colistin; Disease Models, Animal; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Humans; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Pneumonia, Bacterial; Rifampin; Tobramycin | 2004 |
Experimental study of a new vascular graft prebonded with antibiotic: healing, toxicity, and antibiotic retention.
Topics: Animals; Anti-Bacterial Agents; Aorta, Abdominal; Biocompatible Materials; Blood Vessel Prosthesis; Dogs; Gelatin; Giant Cells; Kidney; Liver; Male; Models, Animal; Polyesters; Prosthesis Design; Prosthesis-Related Infections; Rifampin; Surface Properties; Thrombosis; Time Factors; Tobramycin; Tunica Intima; Wound Healing | 2007 |
Prevention of Staphylococcus aureus graft infection by a new gelatin-sealed vascular graft prebonded with antibiotics.
Topics: Animals; Antibiotics, Antitubercular; Aorta, Abdominal; Blood Vessel Prosthesis; Dogs; Female; Gelatin; Male; Prosthesis Design; Prosthesis-Related Infections; Rifampin; Staphylococcal Infections; Tobramycin | 2007 |
Transconjunctival orbital invasion by methicillin-resistant Staphylococcus aureus.
Topics: Adult; Anti-Bacterial Agents; Conjunctivitis; Drug Therapy, Combination; Eye Infections, Bacterial; Humans; Male; Methicillin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Orbital Diseases; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Tobramycin; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2009 |
Successful management of methicillin-resistant Staphylococcus aureus orbital cellulitis after blepharoplasty.
Topics: Administration, Oral; Adult; Anti-Bacterial Agents; Blepharoplasty; Dexamethasone; Drug Therapy, Combination; Humans; Infusions, Intravenous; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Ophthalmic Solutions; Orbital Cellulitis; Rifampin; Staphylococcal Infections; Surgical Wound Infection; Tobramycin; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2010 |
Prolonged triple therapy for persistent multidrug-resistant Acinetobacter baumannii ventriculitis.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Anti-Bacterial Agents; Cerebral Ventriculitis; Colistin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Rifampin; Tobramycin; Treatment Outcome; Vancomycin | 2011 |
Emergence of rifampicin, tigecycline, and colistin-resistant Acinetobacter baumannii in Iran; spreading of MDR strains of novel International Clone variants.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Ampicillin; Anti-Bacterial Agents; Bacterial Typing Techniques; Clone Cells; Colistin; Drug Resistance, Multiple, Bacterial; Humans; Intensive Care Units; Iran; Microbial Sensitivity Tests; Minocycline; Multiplex Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Prevalence; Rifampin; Sulbactam; Tertiary Healthcare; Tigecycline; Tobramycin | 2013 |
Evaluation of sorption capacity of antibiotics and antibacterial properties of a cyclodextrin-polymer functionalized hydroxyapatite-coated titanium hip prosthesis.
Topics: Adsorption; Anti-Bacterial Agents; beta-Cyclodextrins; Delayed-Action Preparations; Drug Carriers; Drug Combinations; Drug Liberation; Enterobacter cloacae; Hip Prosthesis; Hydroxyapatites; Rifampin; Staphylococcus aureus; Surface Properties; Titanium; Tobramycin | 2014 |
Effects of various antibiotics alone or in combination with doripenem against Klebsiella pneumoniae strains isolated in an intensive care unit.
Topics: Carbapenems; Colistin; Doripenem; Dose-Response Relationship, Drug; Drug Combinations; Humans; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Levofloxacin; Minocycline; Rifampin; Tigecycline; Tobramycin | 2014 |
Combined local and systemic antibiotic treatment is effective against experimental Staphylococcus aureus peri-implant biofilm infection.
Topics: Animals; Anti-Bacterial Agents; Biofilms; Ceftriaxone; Female; Femur; Gentamicins; Prostheses and Implants; Rats; Rats, Sprague-Dawley; Rifampin; Sepsis; Staphylococcal Infections; Stem Cells; Time Factors; Tobramycin; Vancomycin | 2015 |
Polymyxin B
Topics: Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Drug Synergism; Polymyxins; Pseudomonas aeruginosa; Rifampin; Tobramycin; Vancomycin | 2017 |
Rifampin and tobramycin combination with PMMA antibiotic cement.
Topics: Anti-Bacterial Agents; Bone Cements; Materials Testing; Polymerization; Polymethyl Methacrylate; Rifampin; Time Factors; Tobramycin | 2019 |
Halicin Is Effective Against Staphylococcus aureus Biofilms In Vitro.
Topics: Animals; Anti-Bacterial Agents; Biofilms; Cefazolin; Mice; Microbial Sensitivity Tests; Reproducibility of Results; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Thiadiazoles; Tobramycin; Vancomycin | 2022 |
Antimicrobial Activity of a Triple Antibiotic Combination Toward Ocular Pseudomonas aeruginosa Clinical Isolates.
Topics: Anti-Bacterial Agents; Bacitracin; Drug Combinations; Erythromycin; Framycetin; Humans; Keratitis; Levofloxacin; Moxifloxacin; Polymyxin B; Pseudomonas aeruginosa; Pseudomonas Infections; Rifampin; Tobramycin; Trimethoprim | 2022 |